DeFi Capital Markets, Inc.: Form 10-Q for the period ended Dec 31, 2018
Filed with the SEC on Feb 19, 2019 and accepted by EDGAR at Feb 19, 2019, 17:02 ET.
Management's discussion and analysis
As filed, 22,813 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
As used throughout this Report, “we,” “our,” “the Company” “USI” and similar words refers to Universal Security Instruments, Inc.
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains certain forward-looking statements reflecting our current expectations with respect to our operations, performance, financial condition, and other developments. These forward-looking statements may generally be identified by the use of the words “may”, “will”, “believes”, “should”, “expects”, “anticipates”, “estimates”, and similar expressions. These statements are necessarily estimates reflecting management’s best judgment based upon current information and involve a number of risks and uncertainties. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made, and readers are advised that various factors could affect our financial performance and could cause our actual results for future periods to differ materially from those anticipated or projected. While it is impossible to identify all such factors, such factors include, but are not limited to, those risks identified in our periodic reports filed with the Securities and Exchange Commission.
overview
We are in the business of marketing and distributing safety and security products which are primarily manufactured through our 50%-owned Hong Kong Joint Venture. Our financial statements detail our sales and other operational results only, and report the financial results of the Hong Kong Joint Venture using the equity method. Accordingly, the following discussion and analysis of the three and nine month periods ended December 31, 2018 and 2017 relate to the operational results of the Company. A discussion and analysis of the Hong Kong Joint Venture’s operational results for these periods is presented below under the heading “Joint Venture.”
The Company has developed new products based on new smoke and gas detection technologies, with what the Company believes are improved sensing technology and product features. To date we have applied for thirteen patents on these new technologies and features. We have been granted ten patents (including six for new technologies and features). Most of our new technologies and features have been trademarked under the trade name IoPhic.
Changes in international trade duties and other aspects of international trade policy, both in the U.S. and abroad, could materially impact the cost of our products. All of our products are imported from the Peoples Republic of China (PRC). To date, our ground fault circuit interrupters (GFCI), which constitute only a small portion of our sales, have been included in products subject to a new 25% tariff effective August 23, 2018. Additionally, on September 28, 2018, tariffs of 10% have been imposed on our Carbon Monoxide and Photoelectric alarms. We are monitoring these developments and will determine our strategies as additional information becomes available. Any increase in tariffs that is not offset by an increase in our sales prices could have an adverse effect on our business, financial position, results of operations or cash flows.
Results of Operations
Three Months Ended December 31, 2018 and 2017
Sales. Net sales for the three months ended December 31, 2018 were $4,491,862 compared to $3,555,431 for the comparable three months in the prior year, an increase of $936,431 (26.3%). Sales increased principally due to increased volume of the Company’s line of sealed battery safety alarms and sales of GFCI’s and other electrical devices not marketed in the prior fiscal year.
Gross Profit Margin. Gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. Our gross profit margin was 23.6% and 30.0% of sales for the quarters ended December 31, 2018 and 2017, respectively. The decrease in gross profit margin was primarily due to the imposition of new tariffs which took effect during the quarter and to the mix of products sold to differing customers.
Expenses. Selling, general and administrative expenses were generally comparable at $1,120,585 for the three months ended December 31, 2018, compared to $1,136,033 for the comparable three months in the prior year. As a percentage of net sales, these expenses decreased to 24.9% for the three month period ended December 31, 2018, from 32.0% for the 2017 period. These expenses decreased as a percentage of net sales since selling, general, and administrative expenses do not increase in direct proportion to increased sales
Research and development expenses were $86,461 for the three month period ended December 31, 2018 compared to $169,521 for the comparable quarter of the prior year, a decrease of $83,060 (49.0%). The primary reason for the decrease is the completion of independent testing and a reduction in salaries expense.
Interest Expense. Our interest expense was $115,924 for the quarter ended December 31, 2018, compared to interest expense of $100,085 for the quarter ended December 31, 2017. Interest expense is dependent upon the total amounts borrowed on average from the Factor and on extended trade payables due to the Hong Kong Joint Venture and on interest rates that have increased during this fiscal quarter. Amounts due to the Hong Kong Joint Venture increased in the current fiscal year’s three month period as compared to the same period in the prior fiscal year.
Net Loss. We reported a net loss of $516,993 for the quarter ended December 31, 2018, compared to a net loss of $1,014,796 for the corresponding quarter of the prior fiscal year, a $497,803 (49.1%) decrease in the net loss. The primary reasons for the decrease in the net loss are the reduction in the net loss of the Hong Kong Joint Venture.
Nine Months Ended December 31, 2018 and 2017
Sales. Net sales for the nine months ended December 31, 2018 were $13,064,110 compared to $10,456,484 for the comparable nine months in the prior period, an increase of $2,607,626 (24.9%). Sales increased principally due to increased volume of the Company’s line of sealed battery safety alarms and sales of GFCI’s and other electrical devices not marketed in the prior fiscal year.
Gross Profit Margin. The gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. The Company’s gross profit margin was 28.8% for the nine month period ended December 31, 2018 and 30.7% for the nine month period ended December 31, 2017. The decrease in gross profit margin was primarily due to the imposition of new tariffs which took effect during the third fiscal quarter and to the mix of products sold to differing customers.
Expenses. Selling, general and administrative expenses were generally comparable at $3,416,924 for the nine months ended December 31, 2018 compared to $3,425,754 for the comparable nine months in the prior year. As a percentage of sales, these expenses were 26.2% for the nine month period ended December 31, 2018 and 32.8% for the comparable 2017 period. These expenses decreased as a percentage of net sales since selling, general, and administrative expenses do not increase in direct proportion to increased sales.
Research and development expenses were $360,766 for the nine months ended December 31, 2018 compared to $512,945 for the comparable period of the prior year, a decrease of $152,179 (29.7%). The primary reason for the decrease is the completion of independent testing and a reduction in salaries expense.
Interest Expense. Our interest expense was $293,277 for the nine months ended December 31, 2018, compared to interest expense of $140,728 for the nine months ended December 31, 2017. Interest expense is dependent upon the total amounts borrowed on average from the Factor and from our Hong Kong Joint Venture and on interest rates that have increased during this fiscal year. Amounts borrowed from the Factor and the Hong Kong Joint Venture increased in the current fiscal year’s nine month period as compared to the same period in the prior fiscal year resulting in the increase in interest expense noted above.
Net Loss. We reported a net loss of $1,077,150 for the nine months ended December 31, 2018 compared to a net loss of $1,726,384 for the corresponding period of the prior fiscal year, a decrease in the net loss of $649,234 (37.6%). The primary reason for the decrease in the net loss is the increase in sales partially offset by the imposition of the new tariffs.
Joint Venture
Net Sales. Net sales of the Joint Venture for the three and nine months ended December 31, 2018 were $3,218,878 and $11,175,101 respectively, compared to $2,099,592 and $10,169,231, respectively, for the comparable period in the prior fiscal year. The 53.3% and 9.9% increases in net sales by the Joint Venture for the respective three and nine month periods are due to increased sales to the Company.
Gross Profit Margin. Gross margins of the Joint Venture for the three month period ended December 31, 2018 increased to 13.1% from (3.4)% for the 2017 corresponding period. For the nine month period ended December 31, 2018, gross margins were 13.8% compared to 15.5% for the same period of the prior year. Gross margins depend on sales volume of various products, with varying margins. In addition, foreign currency exchange gains and/or losses impact gross margins.
Expenses. Selling, general and administrative expenses were $1,022,455 and $3,265,526 respectively, for the three and nine month periods ended December 31, 2018, compared to $1,134,807 and $3,377,504 in the prior year’s respective periods. As a percentage of sales, expenses were 31.8% and 29.2% for the three and nine month periods ended December 31, 2018, compared to 54.1% and 33.2% for the three and nine month periods ended December 31, 2017. The changes in selling, general and administrative expense as a percent of sales for the three and nine month periods were primarily due to costs that do not change at the same rate as changes in sales volume.
Interest Income. Interest income on assets held for investment was $25,664 and $94,667 respectively, for the three and nine month periods ended December 31, 2018, compared to interest income of $63,298 and $229,544, respectively, for the prior year’s periods. Interest income is dependent on yields and on the average balance of assets held for investment.
Net Loss. Net losses for the three and nine months ended December 31, 2018 were $426,316 and $1,175,720, respectively, compared to net losses of $1,059,334 and $1,561,216, respectively, in the comparable period last year. The decrease in the net loss for the three and nine month periods ended December 31, 2018 is due primarily to increased sales to the Company.
Liquidity. Cash needs of the Joint Venture are currently met by funds generated from operations. During the nine months ended December 31, 2018, working capital increased by $1,814,488 from $9,808,216 on March 31, 2018 to $11,622,704 on December 31, 2018.
Management Plans and Liquidity
The Company had net losses of $1,077,150 for the nine months ended December 31, 2018 and $2,262,310 and $2,058,902 for the years ended March 31, 2018 and 2017, respectively. Furthermore, as of December 31, 2018, working capital (computed as the excess of current assets over current liabilities) decreased by $295,656 from $2,632,344 at March 31, 2018, to $2,336,688 at December 31, 2018.
Our short-term borrowings to finance operating losses, trade accounts receivable, and foreign inventory purchases are provided pursuant to the terms of our Factoring Agreement (Agreement) with Merchant Factor Corporation (Merchant or Factor). Advances from the Company’s factor, are at the sole discretion of Merchant based on their assessment of the Company’s receivables, inventory and financial condition at the time of each request for an advance. At December 31, 2018, the Company had approximately $400,000 of availability on the facility with Merchant. In addition, we have secured extended payment terms for purchases up to $4,000,000 from Eyston Company Limited, our Hong Kong Joint Venture for the purchase of the sealed battery products. These amounts are unsecured and have repayment terms of one hundred-twenty days for each advance thereunder. The interest rate on amounts due to the Hong Kong Joint Venture is 5.5%. At December 31, 2018, the balance of accounts payable due to the Hong Kong Joint Venture was $5,833,162.
The Company has a history of sales that are insufficient to generate profitable operations, and has limited sources of financing. Management’s plan in response to these conditions includes increasing sales resulting from the delivery of the Company’s line of sealed battery ionization smoke alarms and carbon monoxide products, and obtaining additional financing on its credit facility. The Company has seen positive results on this plan during the fiscal years ended March 31, 2018 and 2017 and through December 31, 2018 due to sales of its sealed battery products and management expects this growth to continue going forward. Though no assurances can be given, if management’s plan continues to be successful over the next twelve months, the Company anticipates that it should be able to meet its cash needs for the next twelve months following the issuance date of this report. Cash flows and credit availability is expected to be adequate to fund operations for one year from the issuance date of this report.
Operating activities provided cash of $99,629 for the nine months ended December 31, 2018. This was primarily due to an increase in accounts payable and accrued expenses of $2,250,962 and offset by a net loss of $1,077,150 and an increase in accounts receivable of $178,028, and an increase in inventories, prepaid expenses and other of $1,677,649. The net loss includes a non-cash loss from the investment in the Hong Kong Joint Venture of $764,197.
Operating activities provided cash of $689,175 for the nine months ended December 31, 2017. This was primarily due to an increase in accounts payable and accrued expenses of $2,307,303 and offset by a net loss of $1,726,384 and an increase in accounts receivable of $230,183, and in increase in inventories, prepaid expenses and other of $539,971. The net loss includes a non-cash loss from the investment in the Hong Kong Joint Venture of $854,826.
There were no investing activities for the nine months ended December 31, 2018. Investing activities used cash during the nine months ended December 31, 2017 resulting from the purchase of $16,106 in equipment.
Financing activities used cash of $83,442 during the nine months ended December 31, 2018 and used cash of $882,899 during the nine months ended December 31, 2017, which is comprised of net repayments on the line of credit from our factor.
Critical Accounting Policies
Management’s discussion and analysis of our condensed consolidated financial statements and results of operations are based on our condensed consolidated financial statements included as part of this document. The preparation of these condensed consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate these estimates, including those related to bad debts, inventories, income taxes, and contingencies and litigation. We base these estimates on historical experiences, future projections and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Actual results may differ from these estimates under different assumptions or conditions.
We believe the following critical accounting policies affect management’s more significant judgments and estimates used in the preparation of its condensed consolidated financial statements. For a detailed discussion on the application on these and other accounting policies, see Note A to the consolidated financial statements included in Item 8 of the Form 10-K for the year ended March 31, 2018 as filed with the Securities and Exchange Commission on July 16, 2018. Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty and actual results could differ from these estimates. These judgments are based on our historical experience, terms of existing contracts, current economic trends in the industry, information provided by our customers, and information available from outside sources, as appropriate. Our critical accounting policies include:
Revenue Recognition. In June 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers: Topic 606. ASU 2014-09 affects any entity using US GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance. This ASU also supersedes some cost guidance included in Subtopic 605-35, Revenue Recognition—Construction-Type and Production-Type Contracts. In addition, the requirements for the recognition of a gain or loss on the transfer of nonfinancial assets that are not in a contract with a customer (e.g., assets within the scope of Topic 360, Property, Plant, and Equipment, and intangible assets within the scope of Topic 350, Intangibles—Goodwill and Other) are amended to be consistent with the guidance on recognition and measurement (including the constraint on revenue) in this ASU.
The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: Step 1: Identify the contract(s) with a customer. Step 2: Identify the performance obligations in the contract. Step 3: Determine the transaction price. Step 4: Allocate the transaction price to the performance obligations in the contract. Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation. This guidance is effective for annual periods beginning on or after December 15, 2017, including interim reporting periods within that reporting period and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application.
In December 2016 the FASB issued Accounting Standards Update No. 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers, or ASU 2016-20. The amendments in ASU 2016-20 update and affect narrow aspects of the guidance issued in ASU 2014-09. In May 2016, the FASB issued ASU 2016-12, Narrow Scope Improvements and Practical Expedients, which provided revised guidance on certain issues relating to revenue from contracts with customers, including clarification of the objective of the collectability criterion. In March 2016, the FASB issued a final amendment to clarify the implementation guidance for principal versus agent considerations and in April 2016 issued a final amendment to clarify the guidance related to identifying performance obligations and the accounting for intellectual property licenses. The Company adopted this new accounting standard on April 1, 2018 which did not have a material impact on the condensed consolidated financial statements and footnote disclosures.
Inventories. Inventories are valued at the lower of cost or net realizable value. Cost is determined on the first-in first-out method. We evaluate inventories on a quarterly basis and write down inventory that is deemed obsolete or unmarketable in an amount equal to the difference between the cost of inventory and the estimated net realizable value based upon assumptions about future demand and market conditions.
Income Taxes. The Company files its income tax returns in the U.S. federal jurisdiction, and various state jurisdictions. Income tax returns filed for the fiscal years ended March 31, 2018, 2017, and 2016 are considered open and subject to examination by tax authorities. Deferred income tax assets and liabilities are computed and recognized for those differences that have future tax consequences and will result in net taxable or deductible amounts in future periods. Deferred tax expense or benefit is the result of changes in the net asset or liability for deferred taxes. The deferred tax liabilities and assets for the Company result primarily from net operating loss and tax credit carry forwards, reserves and accrued liabilities. We calculate our interim tax provision in accordance with the guidance for accounting for income taxes in interim periods. We estimate the annual effective tax rate and apply that tax rate to our ordinary quarterly pre-tax income. The tax expense or benefit related to discrete events during the interim period is recognized in the interim period in which those events occurred.
The Company follows ASC 740-10 which provides guidance for tax positions related to the recognition and measurement of a tax position taken or expected to be taken in a tax return and requires that we recognize in our consolidated financial statements the impact of a tax position, if that position is more likely than not to be sustained upon an examination, based on the technical merits of the position. Interest and penalties, if any, related to income tax matters are recorded as income tax expenses.
Off-Balance Sheet Arrangements. We have not created, and are not party to, any special-purpose or off balance sheet entities for the purpose of raising capital, incurring debt or operating parts of our business that are not consolidated into our condensed financial statements and do not have any arrangements or relationships with entities that are not consolidated into our condensed financial statements that are reasonably likely to materially affect our liquidity or the availability of our capital resources.
Controls and procedures
As filed, 1,734 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain a system of disclosure controls and procedures (as such item is defined in Rules 13a – 15(e) and 15d – 15(e) of the Exchange Act) that is designed to provide reasonable assurance that information, which is required to be disclosed by us in the reports that we file or submit under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and is accumulated and communicated to management in a timely manner. Our Chief Executive Officer and Chief Financial Officer have evaluated this system of disclosure controls and procedures in accordance with applicable Securities and Exchange Commission guidance as of the end of the period covered by this quarterly report, and have concluded that disclosure controls and procedures were not effective because of the material weakness in internal control over financial reporting as discussed below.
Material weaknesses arose in our oversight of the accounting function and disclosure controls and procedures of the Hong Kong Joint Venture (HKJV). The HKJV is a material component of the Company’s consolidated financial statements. The Company has discussed this weakness with management of the HKJV and is monitoring implementation of suggested improvements.
Changes in Internal Control over Financial Reporting. There have not been any changes in our internal control over financial reporting that occurred during the quarter ended December 31, 2018 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-10-01 to 2018-12-31 | $4.5m | us-gaap:Revenues |
| Revenue | 9 months2018-04-01 to 2018-12-31 | $13.1m | us-gaap:Revenues |
| Gross profit | 3 months2018-10-01 to 2018-12-31 | $1.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2018-04-01 to 2018-12-31 | $3.8m | us-gaap:GrossProfit |
| Research and development | 3 months2018-10-01 to 2018-12-31 | $86.5k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2018-04-01 to 2018-12-31 | $360.8k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2018-10-01 to 2018-12-31 | $1.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2018-04-01 to 2018-12-31 | $3.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-10-01 to 2018-12-31 | −$145.7k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2018-04-01 to 2018-12-31 | −$19.7k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-10-01 to 2018-12-31 | $115.9k | us-gaap:InterestExpense |
| Interest expense | 9 months2018-04-01 to 2018-12-31 | $293.3k | us-gaap:InterestExpense |
| Net income | 3 months2018-10-01 to 2018-12-31 | −$517.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2018-04-01 to 2018-12-31 | −$1.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-10-01 to 2018-12-31 | −$0.22 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2018-04-01 to 2018-12-31 | −$0.47 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2018-04-01 to 2018-12-31 | $99.6k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2018-12-31 | $144.3k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-12-31 | $10.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-12-31 | $19.3m | us-gaap:Assets |
| Current liabilities | At period end2018-12-31 | $8.3m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2018-12-31 | $11.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-19-008907. Last ingested by Listed: Nov 4, 2026, 06:09 ET. Listed shows no prices and gives no investment advice.